{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:11:46Z","timestamp":1778911906093,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005624","name":"PATH","doi-asserted-by":"publisher","award":["3328"],"award-info":[{"award-number":["3328"]}],"id":[{"id":"10.13039\/100005624","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005624","name":"PATH","doi-asserted-by":"publisher","award":["WA 98107"],"award-info":[{"award-number":["WA 98107"]}],"id":[{"id":"10.13039\/100005624","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine: X"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jvacx.2022.100179","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T12:53:41Z","timestamp":1655124821000},"page":"100179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Expanding japanese encephalitis vaccination to selected endemic indonesia provinces: A cost-effectiveness analysis"],"prefix":"10.1016","volume":"11","author":[{"given":"Soewarta","family":"Kosen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levina Chandra","family":"Khoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Endang","family":"Indriasih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingan","family":"Tarigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Retno Widyastuti","family":"Iriawan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rozana Ika","family":"Agustiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G William","family":"Letson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Vodicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvacx.2022.100179_b0005","unstructured":"WHO. Japanese Encephalitis: Key Facts. At Https:\/\/Www.Who.Int\/News-Room\/Fact-Sheets\/Detail\/Japanese-Encephalitis#:~:Text=Japanese%20encephalitis%20virus%20(JEV)%20is,000%20clinical%20cases%20every%20year. Last Updated: September 2019 [accessed August 2020]."},{"issue":"10","key":"10.1016\/j.jvacx.2022.100179_b0010","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2471\/BLT.10.085233","article-title":"Estimated global incidence of Japanese encephalitis: a systematic review","volume":"89","author":"Campbell","year":"2011","journal-title":"Bull World Health Organ"},{"issue":"90","key":"10.1016\/j.jvacx.2022.100179_b0015","first-page":"69","article-title":"Japanese Encephalitis Vaccines: WHO Position Paper - February 2015","volume":"9","author":"World Health Organization","year":"2015","journal-title":"Weekly Epidemiological Rec"},{"key":"10.1016\/j.jvacx.2022.100179_b0020","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.actatropica.2018.08.017","article-title":"Japanese encephalitis in Indonesia: An update on epidemiology and transmission ecology","volume":"187","author":"Garjito","year":"2018","journal-title":"Acta Trop"},{"issue":"6","key":"10.1016\/j.jvacx.2022.100179_b0025","doi-asserted-by":"crossref","first-page":"e389","DOI":"10.1016\/j.ijid.2009.01.009","article-title":"Outcome and extent of disability following Japanese encephalitis in Indonesian children","volume":"13","author":"Maha","year":"2009","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jvacx.2022.100179_b0030","unstructured":"Burni E. Vector borne diseases and zoonotic policy in Indonesia. National Seminar on Rikhus Vectora Final Report; 2017, 17\u201319 December 2017, Yogyakarta."},{"key":"10.1016\/j.jvacx.2022.100179_b0035","unstructured":"Results of Special Research on Disease Vector in Indonesia 2014\u20132017, National Institute of Health Research and Development, Jakarta, Indonesia [Unpublished]."},{"issue":"6","key":"10.1016\/j.jvacx.2022.100179_b0040","doi-asserted-by":"crossref","first-page":"963","DOI":"10.4269\/ajtmh.2008.79.963","article-title":"Confirmation of Japanese encephalitis as an endemic human disease through sentinel surveillance in Indonesia","volume":"79","author":"Maha","year":"2008","journal-title":"Am J Trop Med Hyg"},{"issue":"35","key":"10.1016\/j.jvacx.2022.100179_b0045","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1016\/j.vaccine.2008.06.050","article-title":"Cost-effectiveness of Japanese encephalitis (JE) immunization in Bali, Indonesia","volume":"26","author":"Liu","year":"2008","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.jvacx.2022.100179_b0050","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1016\/j.vaccine.2020.02.018","article-title":"Japanese encephalitis vaccination in the Philippines: A cost-effectiveness analysis comparing alternative delivery strategies","volume":"38","author":"Vodicka","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2022.100179_b0055","unstructured":"Ministry of Health, Government of Indonesia. Report on Immunization Program; 2018."},{"issue":"12","key":"10.1016\/j.jvacx.2022.100179_b0060","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.4161\/21645515.2014.980197","article-title":"Immunogenicity and safety of currently available Japanese encephalitis vaccines: A systematic review","volume":"10","author":"Li","year":"2014","journal-title":"Hum Vaccines Immunother"},{"issue":"1","key":"10.1016\/j.jvacx.2022.100179_b0065","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7015-4-8","article-title":"A hospital-based surveillance for Japanese encephalitis in Bali, Indonesia","volume":"4","author":"Kari","year":"2006","journal-title":"BMC Med."},{"issue":"2","key":"10.1016\/j.jvacx.2022.100179_b0070","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.pneurobio.2010.01.008","article-title":"Overview: Japanese encephalitis","volume":"91","author":"Misra","year":"2010","journal-title":"Prog Neurobiol"},{"issue":"11","key":"10.1016\/j.jvacx.2022.100179_b0075","doi-asserted-by":"crossref","first-page":"e712","DOI":"10.1016\/S2214-109X(15)00069-8","article-title":"Disability weights for the Global Burden of Disease 2013 study","volume":"3","author":"Salomon","year":"2015","journal-title":"Lancet Glob Heal"},{"key":"10.1016\/j.jvacx.2022.100179_b0080","unstructured":"Indonesia Health Technology Assessment. Economic evaluation of Cetuximab for metastatic colorectal cancer patients; 2017."},{"issue":"5","key":"10.1016\/j.jvacx.2022.100179_b0085","first-page":"334","article-title":"Cost-effectiveness of routine immunization to control Japanese encephalitis in Shanghai, China","volume":"81","author":"Ding","year":"2003","journal-title":"Bull World Health Organ"},{"issue":"29","key":"10.1016\/j.jvacx.2022.100179_b0090","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1016\/j.vaccine.2010.04.086","article-title":"A cost\u2013effectiveness analysis of Japanese encephalitis vaccine in Cambodia","volume":"28","author":"Touch","year":"2010","journal-title":"Vaccine"},{"issue":"37","key":"10.1016\/j.jvacx.2022.100179_b0095","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.1016\/j.vaccine.2012.05.068","article-title":"An economic evaluation of the use of Japanese encephalitis vaccine in the expanded program of immunization of Guizhou province, China","volume":"30","author":"Yin","year":"2012","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.jvacx.2022.100179_b0100","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2471\/BLT.15.164418","article-title":"Cost\u2013effectiveness thresholds: pros and cons","volume":"94","author":"Bertram","year":"2016","journal-title":"Bull World Health Organ"},{"issue":"7","key":"10.1016\/j.jvacx.2022.100179_b0105","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jval.2017.12.016","article-title":"Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies","volume":"21","author":"Leech","year":"2018","journal-title":"Value Heal"},{"issue":"2","key":"10.1016\/j.jvacx.2022.100179_b0110","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2471\/BLT.14.138206","article-title":"Thresholds for the cost\u2013effectiveness of interventions: Alternative approaches","volume":"93","author":"Marseille","year":"2015","journal-title":"Bull World Health Organ"},{"issue":"8","key":"10.1016\/j.jvacx.2022.100179_b0115","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.jval.2016.02.017","article-title":"Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research","volume":"19","author":"Woods","year":"2016","journal-title":"Value Heal"},{"key":"10.1016\/j.jvacx.2022.100179_b0120","unstructured":"Sagung Sawitri AA, Cintya Yuliatni PC, Dwi Ariawan IM, Kartika Sari KA. Coverage evaluation of Japanese encephalitis Supplementary Immunization Activities (JE SIA) in Bali Island. Faculty of Medicine University of Udayana; 2018."}],"container-title":["Vaccine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136222000390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136222000390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T05:51:51Z","timestamp":1778910711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590136222000390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":24,"alternative-id":["S2590136222000390"],"URL":"https:\/\/doi.org\/10.1016\/j.jvacx.2022.100179","relation":{},"ISSN":["2590-1362"],"issn-type":[{"value":"2590-1362","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expanding japanese encephalitis vaccination to selected endemic indonesia provinces: A cost-effectiveness analysis","name":"articletitle","label":"Article Title"},{"value":"Vaccine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvacx.2022.100179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100179"}}